Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X

Coronary Artery Disease

Volumn 18, Issue 7, 2007, Pages 539-544

  Okyay, Kaan ^a   Cengel, Atiye ^a   Sahinarslan, Asife ^a   Tavil, Yusuf ^a   Turkoglu, Sedat ^a   Biberoglu, Gulser ^a   Hasanoglu, Alev ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Asymmetric dimethylarginine; Myocardial blush grade; Normal coronary arteries

Indexed keywords

ARGININE; N(G),N(G) DIMETHYLARGININE;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC SYNDROME X; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EPICARDIUM; FEMALE; HEART MUSCLE PERFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MYOCARDIAL BLUSH GRADE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; THROMBOLYSIS IN MYOCARDIAL INFARCTION FRAME COUNT; TREADMILL EXERCISE;

AGED; ARGININE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; EXERCISE TEST; FEMALE; HUMANS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; MYOCARDIUM; NITRIC OXIDE; PERFUSION; PERICARDIUM;

EID: 35048833781     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f08ece     Document Type: Article

References (35)

1. Kennedy JW, Killip T, Fisher LD, Alderman EL, Gillespie MJ, Mock MB. The clinical spectrum of coronary artery disease and its surgical and medical management, 1974-1979. The Coronary Artery Surgery Study. Circulation 1982; 66:III16-III23.
2. Kemp HG Jr, Vokoanas PS, Cohn PF, Gorlin R. The anginal syndrome associated with normal coronary arteriograms. Report of a six year experience. Am J Med 1973; 54:735-742.
3. Al Suwaidi J, Higano ST, Holmes DR Jr, Lerman A. Pathophysiology, diagnosis, and current management strategies for chest pain in patients with normal findings on angiography. Mayo Clin Proc 2001; 76:813-822.
4. Hurst T, Olson TH, Olson LE, Appleton CP. Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment. Am J Med 2006; 119:560-566.
5. Vane JR, Auggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36.
6. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease. N Engl J Med 1992; 326:242-250.
7. De Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85:2284-2290.
8. Cengel A, Sahinarslan A. Nitric oxide and cardiovascular system. Anadolu Kardiyol Derg 2006; 6:364-368.
9. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
10. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20 (Suppl 12):S60-S62.
11. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98:1842-1847.
12. Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, et al. LDL cholesterol upregulates synthesis of asymmetric dimethylarginine in human endothelial cells. Involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 2000; 87:99-105.
13. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20:2032-2037.
14. Takiuchi S, Fujii H, Kamide K, Horio T, Nakatani S, Hiuge A, et al. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am J Hypertens 2004; 17:802-808.
15. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, et al. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005; 46:518-523.
16. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count. A quantitative method of assessing coronary artery flow. Circulation 1996; 93:879-888.
17. Van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998; 97:2302-2306.
18. Atmaca Y, Ozdemir AO, Ozdol C, Oguz D, Gulec S, Kumbasar D, et al. Angiographic evaluation of myocardial perfusion in patients with syndrome X. Am J Cardiol 2005; 96:803-805.
19. Sen N, Tavil Y, Yazici HU, Abaci A, Cengel A. Coronary blood flow in patients with cardiac syndrome X. Coron Artery Dis 2007; 18:45-48.
20. G-dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatography B 1997; 692:467-471.
21. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boger RH, Bode-Boger SM, et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 1999; 33:652-658.
22. Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002; 287:1420-1426.
23. Sydow K, Schwedhelm E, Arakawa N, Bode-Boger SM, Tsikas D, Hornig B, et al. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocys(e)inemia: effects of L-arginine and B vitamins. Cardiovasc Res 2003; 57:244-252.
24. Wang J, Sim AS, Wang XL, Salonikas C, Naidoo D, Wilcken DE. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease. Atherosclerosis 2006; 184:383-388.
25. Ngo DTM, Heresztyn T, Mishra K, Marwick TH, Horowitz CD. Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA). Nitric Oxide 2007; 16:197-201.
26. Sahinarslan A, Cengel A, Biberoglu G, Hasanoglu A, Turkoglu S, Timurkaynak T. Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography. Coron Artery Dis 2006; 17:605-609.
27. Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterjiel KZ, Goudeva L, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 2006; 152:493. e1-e8.
28. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary arteriograms. Circulation 1996; 94:130-134.
29. Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS. Long-term angiotensin- converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 2002; 90:974-982.
30. Piatti PM, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I, et al. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms. Correlation with asymmetric dimethylarginine levels. Circulation 2003; 107:429-436.
31. Paiva H, Laakso J, Laine H, Laaksonen H, Knuuti J, Raikatari OT. Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia. J Am Coll Cardiol 2002; 40:1241-1247.
32. Böger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frölich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997; 95:2068-2074.
33. Jadhav ST, Ferrell WR, Petrie JR, Scherbakova O, Greer IA, Cobbe SM, et al. Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. Am J Cardiol 2006; 97:1727-1731.
34. Crea F, Lanza GA. Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004; 90:457-463.
35. Lanza GA, Luscher TF, Pasceri V, Shaw SG, Buffon A, Montenero AS, et al. Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X. Am J Cardiol 1999; 84:1187-1191.